|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,140 KRW | +1.49% |
|
+3.37% | +15.41% |
OPTUS Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 93.07 million compared to KRW 60.15 million a year ago. Net income was KRW 2,049.65 million compared to KRW 2,216.58 million a year ago.
Basic earnings per share from continuing operations was KRW 135 compared to KRW 140 a year ago. Basic earnings per share was KRW 135 compared to KRW 140 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.41% | 72.06M | |
| +4.06% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
OPTUS PHARMACEUTICAL CO., LTD. 
